SENS
- Senseonics Holdings, Inc.
()
Overview
Company Summary
Senseonics Holdings, Inc. is a medical technology company that specializes in the development and commercialization of continuous glucose monitoring (CGM) systems. The company's primary focus is on offering innovative solutions for individuals with diabetes, aiming to improve their quality of life and enhance their diabetes management.
Senseonics' flagship product is known as the Eversense CGM System, which is designed to provide long-term, implantable glucose monitoring capabilities. Unlike traditional CGM systems, which require frequent sensor insertion and replacement, the Eversense system includes a small sensor that is inserted subcutaneously and can provide continuous glucose readings for up to 90 days.
The Eversense CGM System consists of three main components: the sensor, the smart transmitter, and the mobile app. The sensor measures glucose levels in the interstitial fluid beneath the skin and transmits the data wirelessly to the smart transmitter. The transmitter, worn on the body near the sensor, collects the data and sends it to the Eversense mobile app, where users can access real-time glucose readings and receive alerts for high or low levels.
Senseonics' Eversense CGM System has several notable advantages compared to other CGM systems on the market. The long-term implantation feature eliminates the need for frequent sensor insertions, offering a more convenient and comfortable experience for users. Additionally, the system's accuracy and reliability have been clinically validated, providing dependable glucose data for better diabetes management.
Senseonics serves various customers, including individuals with diabetes, healthcare professionals, and diabetes clinics. By providing an innovative and reliable CGM solution, the company aims to empower users to make informed decisions regarding their diabetes treatment and improve their overall health outcomes.
In summary, Senseonics Holdings, Inc. is dedicated to developing and commercializing advanced continuous glucose monitoring systems, with its flagship product, the Eversense CGM System, offering long-term implantable sensors and user-friendly monitoring capabilities for individuals with diabetes.